INOVIO PHARMACEUTICALS, INC. Other-than-temporary Impairment Loss, Debt Securities, Portion Recognized in Earnings
INOVIO PHARMACEUTICALS, INC. (INO) reported Other-than-temporary Impairment Loss, Debt Securities, Portion Recognized in Earnings of $36.00 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings · last filed 2019-05-09
- INOVIO PHARMACEUTICALS, INC. other-than-temporary impairment loss, debt securities, portion recognized in earnings for the quarter ending 2019-03-31 was $36.00K, a 85.77% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. other-than-temporary impairment loss, debt securities, portion recognized in earnings for the quarter ending 2018-12-31 was $742.00K, a 441.61% increase year-over-year.
- INOVIO PHARMACEUTICALS, INC. other-than-temporary impairment loss, debt securities, portion recognized in earnings for the quarter ending 2018-09-30 was $184.00K, a 1572.73% increase year-over-year.
- INOVIO PHARMACEUTICALS, INC. other-than-temporary impairment loss, debt securities, portion recognized in earnings for the quarter ending 2018-06-30 was $121.00K, a 656.25% increase year-over-year.
- INOVIO PHARMACEUTICALS, INC. other-than-temporary impairment loss, debt securities, portion recognized in earnings for fiscal 2018 was $1.30M, a 504.65% increase from fiscal 2017.
- INOVIO PHARMACEUTICALS, INC. other-than-temporary impairment loss, debt securities, portion recognized in earnings for fiscal 2017 was $215.00K.
| Period end | Other-than-temporary Impairment Loss, Debt Securities, Portion Recognized in Earnings 3 month | Other-than-temporary Impairment Loss, Debt Securities, Portion Recognized in Earnings 6 month | Other-than-temporary Impairment Loss, Debt Securities, Portion Recognized in Earnings 9 month | Other-than-temporary Impairment Loss, Debt Securities, Portion Recognized in Earnings 12 month |
|---|---|---|---|---|
| 2019-03-31 | $36.00K 10-Q · filed 2019-05-09 | $778.00K derived: sum of 2 quarters · filed 2019-05-09 | $962.00K derived: sum of 3 quarters · filed 2019-05-09 | $1.08M derived: sum of 4 quarters · filed 2019-05-09 |
| 2018-12-31 | $742.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $926.00K derived: sum of 2 quarters · filed 2019-03-12 | $1.05M derived: sum of 3 quarters · filed 2019-03-12 | $1.30M 10-K · filed 2019-03-12 |
| 2018-09-30 | $184.00K 10-Q · filed 2018-11-08 | $305.00K derived: sum of 2 quarters · filed 2018-11-08 | $558.00K 10-Q · filed 2018-11-08 | $695.00K derived: sum of 4 quarters · filed 2019-05-09 |
| 2018-06-30 | $121.00K 10-Q · filed 2018-08-07 | $374.00K 10-Q · filed 2018-08-07 | $511.00K derived: sum of 3 quarters · filed 2019-05-09 | $522.00K derived: sum of 4 quarters · filed 2019-05-09 |
| 2018-03-31 | $253.00K 10-Q · filed 2019-05-09 | $390.00K derived: sum of 2 quarters · filed 2019-05-09 | $401.00K derived: sum of 3 quarters · filed 2019-05-09 | $417.00K derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $148.00K derived: sum of 2 quarters · filed 2019-03-12 | $164.00K derived: sum of 3 quarters · filed 2019-03-12 | $215.00K 10-K · filed 2019-03-12 |
| 2017-09-30 | $11.00K 10-Q · filed 2018-11-08 | $27.00K derived: sum of 2 quarters · filed 2018-11-08 | $78.00K 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $16.00K 10-Q · filed 2018-08-07 | $67.00K 10-Q · filed 2018-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |